RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+5.38%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$1.43B
AUM Growth
+$1.43B
(+17%)
Cap. Flow
+$174M
Cap. Flow
% of AUM
12.16%
Top 10 Holdings %
Top 10 Hldgs %
28.58%
Holding
96
New
13
Increased
36
Reduced
31
Closed
4
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$34.5M |
| 2 |
Cencora
COR
|
$19.8M |
| 3 |
McKesson
MCK
|
$17.2M |
| 4 |
Intuitive Surgical
ISRG
|
$16.3M |
| 5 |
Abbott
ABT
|
$15M |
Top Sells
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$24.9M |
| 2 |
AbbVie
ABBV
|
$14.3M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12.2M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$9.46M |
| 5 |
Glaukos
GKOS
|
$7.55M |
Sector Composition
| 1 | Healthcare | 96.33% |
| 2 | Industrials | 0.98% |
| 3 | Technology | 0.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Iovance Biotherapeutics
IOVA
$800M
| $9.34M | 0.65% |
295,000
-25,000
| -8% | -$792K |
|
52
Edwards Lifesciences
EW
$47.7B
| $9.2M | 0.64% |
110,000
-15,000
| -12% | -$1.25M |
|
|
ACCD
53
DELISTED
Accolade, Inc. Common Stock
ACCD
| $9.07M | 0.63% |
200,000
+50,000
| +33% | +$2.27M |
|
|
RDUS
54
DELISTED
Radius Health, Inc.
RDUS
| $8.97M | 0.63% |
430,000
-51,826
| -11% | -$1.08M |
|
|
GTHX
55
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $7.82M | 0.55% |
325,000
+85,000
| +35% | +$2.05M |
|
|
ONEM
56
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $7.82M | 0.55% |
+200,000
| New | +$7.82M |
|
57
Dynavax Technologies
DVAX
$1.19B
| $7.73M | 0.54% |
786,211
-139,323
| -15% | -$1.37M |
|
58
ESSA Pharma
EPIX
$11.2M
| $7.55M | 0.53% |
260,000
+103,300
| +66% | +$3M |
|
|
SILK
59
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $7.4M | 0.52% |
146,000
+21,000
| +17% | +$1.06M |
|
60
FibroGen
FGEN
$48.4M
| $6.94M | 0.48% |
200,000
+55,000
| +38% | +$1.91M |
|
61
Phathom Pharmaceuticals
PHAT
$843M
| $6.57M | 0.46% |
175,000
| – | – |
|
|
SWAV
62
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $6.51M | 0.45% |
50,000
-10,000
| -17% | -$1.3M |
|
63
MeiraGTx Holdings
MGTX
$590M
| $6.49M | 0.45% |
450,000
| – | – |
|
64
Adverum Biotechnologies
ADVM
$68.2M
| $6.41M | 0.45% |
650,000
+25,000
| +4% | +$247K |
|
|
OSH
65
DELISTED
Oak Street Health, Inc.
OSH
| $6.24M | 0.44% |
115,000
+55,000
| +92% | +$2.98M |
|
|
INOV
66
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $6.19M | 0.43% |
+215,000
| New | +$6.19M |
|
|
RVNC
67
DELISTED
Revance Therapeutics, Inc.
RVNC
| $6.15M | 0.43% |
220,000
| – | – |
|
|
ALXN
68
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $6.12M | 0.43% |
40,000
-80,000
| -67% | -$12.2M |
|
69
Zai Lab
ZLAB
$3.48B
| $6M | 0.42% |
+45,000
| New | +$6M |
|
70
Royalty Pharma
RPRX
$15.8B
| $5.67M | 0.4% |
130,000
-120,000
| -48% | -$5.23M |
|
71
Biogen
BIIB
$20.8B
| $5.46M | 0.38% |
19,500
-20,500
| -51% | -$5.73M |
|
72
Health Catalyst
HCAT
$228M
| $5.38M | 0.38% |
+115,000
| New | +$5.38M |
|
73
Rigel Pharmaceuticals
RIGL
$710M
| $5.2M | 0.36% |
1,520,000
-216,176
| -12% | -$739K |
|
74
Annexon
ANNX
$225M
| $5.01M | 0.35% |
180,000
+50,000
| +38% | +$1.39M |
|
|
RCM
75
DELISTED
R1 RCM Inc. Common Stock
RCM
| $4.94M | 0.34% |
+200,000
| New | +$4.94M |
|